Theorem Clinical Research

Drug Sponsors

FDA approves first biosimilar Zarxio from Sandoz

Friday, March 6, 2015 12:24 PM

Sandoz, a Novartis company, has became the first company to receive approval of a biosimilar in the U.S. through the new FDA biosimilar pathway established under the Biologics Price Competition and Innovation Act.

More... »

Quest Diagnostics

Mallinckrodt Pharmaceuticals to acquire Ikaria

Friday, March 6, 2015 12:14 PM

Mallinckrodt, a global specialty biopharmaceutical company based in Dublin, through a subsidiary, will acquire Hampton, N.J.-based Ikaria, a privately held critical care company, from a Madison Dearborn-led investor group, in a transaction valued at approximately $2.3 billion.

More... »


AbbVie to acquire Pharmacyclics for $21B, boosting hematological oncology franchise

Thursday, March 5, 2015 12:38 PM

AbbVie has announced a definitive agreement to acquire Pharmacyclics and its flagship asset Imbruvica (ibrutinib), a treatment for hematologic malignancies. 

More... »

Baxter International acquires SuppreMol

Thursday, March 5, 2015 12:35 PM

Baxter International has acquired SuppreMol for approximately $225 million. SuppreMol is a privately held biopharmaceutical company based in Martinsried, Germany, developing treatment options for autoimmune and allergic diseases.

More... »

Johnson & Johnson Innovation opens JLABS @South San Francisco

Wednesday, March 4, 2015 01:30 PM

Johnson & Johnson Innovation has opened JLABS @South San Francisco (JLABS @SSF), a 30,000-square-foot incubator located in South San Francisco, Calif. The Johnson & Johnson Innovation, JLABS site can accommodate up to 50 startups from across the healthcare spectrum including biotech, pharmaceutical, medical device, consumer and digital health. 

More... »

Malin to acquire Serenus Biotherapeutics

Wednesday, March 4, 2015 01:22 PM

Serenus Biotherapeutics, a San Francisco, Calif.-based specialty biopharmaceutical company, has secured investment of up to $43 million from Malin, an Ireland-based global life sciences company focused on healthcare.

More... »

Domain Therapeutics launches Kaldi Pharma

Wednesday, March 4, 2015 01:21 PM

Domain Therapeutics, a France-based biopharmaceutical company specializing in the research and early development of new drug candidates targeting G protein-coupled receptors (GPCRs), has created a Specific Purpose Vehicle (SPV), Kaldi Pharma, for the exclusive development of its A2a/A1 and A2a antagonist programs.

More... »

Cardinal Health to acquire Johnson & Johnson’s Cordis

Wednesday, March 4, 2015 01:18 PM

Johnson & Johnson has received a binding offer from Cardinal Health, a healthcare services company based in Dublin, Ohio, to acquire its Cordis business for an aggregate value of $1.99 billion, consisting of $1.944 billion of cash proceeds from Cardinal Health plus approximately $46 million of retained net receivables. Cordis is a developer and manufacturer of interventional vascular technology with 2014 net revenues of approximately $780 million.

More... »

Sun Pharma to buy GSK’s Opiates business in Australia

Wednesday, March 4, 2015 01:16 PM

GlaxoSmithKline has reached an agreement with India-based Sun Pharma to sell GSK’s opiates business in Australia, including related manufacturing sites in Latrobe (Tasmania) and Port Fairy (Victoria) and its portfolio of opiates products along with inventory, to a subsidiary of Sun Pharma.

More... »

AtheroNova and subsidiary file for Ch. 11 bankruptcy protection

Wednesday, March 4, 2015 01:16 PM

AtheroNova and its subsidiary, AtheroNova Operations, filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court, Central District of California, Santa Ana division on March 2. The company's Chapter 11 cases are expected to be jointly administered.

More... »

AiCure
CWWeekly

March 23

Industry welcomes FDA draft guidance outlining the use of electronic Informed Consent for trials

Apple launches ResearchKit platform to tap millions of iPhone users to enroll in observational studies using apps

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs